These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 21793087)

  • 1. Aberrant right subclavian artery: incidence and correlation with other markers of Down syndrome in second-trimester fetuses.
    Paladini D; Sglavo G; Pastore G; Masucci A; D'Armiento MR; Nappi C
    Ultrasound Obstet Gynecol; 2012 Feb; 39(2):191-5. PubMed ID: 21793087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant right subclavian artery as a new cardiac sign in second- and third-trimester fetuses with Down syndrome.
    Chaoui R; Heling KS; Sarioglu N; Schwabe M; Dankof A; Bollmann R
    Am J Obstet Gynecol; 2005 Jan; 192(1):257-63. PubMed ID: 15672034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant right subclavian artery (ARSA) in unselected population at first and second trimester ultrasonography.
    Rembouskos G; Passamonti U; De Robertis V; Tempesta A; Campobasso G; Volpe G; Gentile M; Volpe P
    Prenat Diagn; 2012 Oct; 32(10):968-75. PubMed ID: 22847746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant right subclavian artery at 16 to 23 + 6 weeks of gestation: a marker for chromosomal abnormality.
    Borenstein M; Minekawa R; Zidere V; Nicolaides KH; Allan LD
    Ultrasound Obstet Gynecol; 2010 Nov; 36(5):548-52. PubMed ID: 20503237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant right subclavian artery in fetuses with Down syndrome: a systematic review and meta-analysis.
    Scala C; Leone Roberti Maggiore U; Candiani M; Venturini PL; Ferrero S; Greco T; Cavoretto P
    Ultrasound Obstet Gynecol; 2015 Sep; 46(3):266-76. PubMed ID: 25586729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal aberrant right subclavian artery (ARSA) - a potential new soft marker in the genetic scan?
    Willruth AM; Dwinger N; Ritgen J; Stressig R; Geipel A; Gembruch U; Berg C
    Ultraschall Med; 2012 Dec; 33(7):E114-E118. PubMed ID: 21614745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-trimester fetal aberrant right subclavian artery: original study, systematic review and meta-analysis of performance in detection of Down syndrome.
    De León-Luis J; Gámez F; Bravo C; Tenías JM; Arias Á; Pérez R; Maroto E; Aguarón Á; Ortiz-Quintana L
    Ultrasound Obstet Gynecol; 2014 Aug; 44(2):147-53. PubMed ID: 24585513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ABERRANT RIGHT SUBCLAVIAN ARTERY (ARSA)--A NEW ULTRASOUND MARKER FOR CHROMOSOMAL FETAL ABNORMALITIES].
    Atanasova D; Markov D; Pavlova E
    Akush Ginekol (Sofiia); 2015; 54(4):12-7. PubMed ID: 26410943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant right subclavian artery at 11 + 0 to 13 + 6 weeks of gestation in chromosomally normal and abnormal fetuses.
    Borenstein M; Cavoretto P; Allan L; Huggon I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Jan; 31(1):20-4. PubMed ID: 18157795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficiency of second-trimester nasal bone hypoplasia and increased nuchal fold in Down syndrome screening.
    Odibo AO; Sehdev HM; Gerkowicz S; Stamilio DM; Macones GA
    Am J Obstet Gynecol; 2008 Sep; 199(3):281.e1-5. PubMed ID: 18771983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suspicious Prenasal Skin Thickness-to-Nasal Bone Length Ratio: Prevalence and Correlation with Other Markers in Second and Third Trimester Fetuses with Down Syndrome.
    Hagen A; Albig M; Keller T; Stumm M; Entezami M
    Ultraschall Med; 2015 Oct; 36(5):501-6. PubMed ID: 26091004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of ultrasound markers in screening fetal trisomy 21].
    Shi XM; Fang Q; Chen BJ; Xie HN; Xie YJ; Chen JH; Wu JZ
    Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):81-5. PubMed ID: 23544486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuchal translucency and nasal bone for trisomy 21 screening: single center experience.
    Monni G; Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C
    Croat Med J; 2005 Oct; 46(5):786-91. PubMed ID: 16158472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-trimester soft markers: relation to first-trimester nuchal translucency in unaffected pregnancies.
    Miguelez J; De Lourdes Brizot M; Liao AW; De Carvalho MH; Zugaib M
    Ultrasound Obstet Gynecol; 2012 Mar; 39(3):274-8. PubMed ID: 21484908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of an Aberrant Right Subclavian Artery on Second-Trimester Sonography in an Unselected Population.
    Gursoy Erzincan S; Karamustafaoglu Balci B; Tokgoz C; Kalelioglu IH
    J Ultrasound Med; 2017 May; 36(5):1015-1019. PubMed ID: 28258603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
    Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
    Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Literature review and suggested protocol for managing ultrasound soft markers for Down syndrome: thickened nuchal fold, echogenic bowel, shortened femur, shortened humerus, pyelectasis and absent or hypoplastic nasal bone.
    Bethune M
    Australas Radiol; 2007 Jun; 51(3):218-25. PubMed ID: 17504311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated absent or hypoplastic nasal bone in the second trimester fetus: is amniocentesis necessary?
    Ting YH; Lao TT; Lau TK; Chung MK; Leung TY
    J Matern Fetal Neonatal Med; 2011 Apr; 24(4):555-8. PubMed ID: 21375370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for trisomy 21 during the routine second-trimester ultrasound examination in an unselected Chilean population.
    Parra-Cordero M; Quiroz L; Rencoret G; Pedraza D; Muñoz H; Soto-Chacón E; Miranda-Mendoza I
    Ultrasound Obstet Gynecol; 2007 Dec; 30(7):946-51. PubMed ID: 17987599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac malformations in first-trimester fetuses with increased nuchal translucency: ultrasound diagnosis and postmortem morphology.
    Haak MC; Bartelings MM; Gittenberger-De Groot AC; Van Vugt JM
    Ultrasound Obstet Gynecol; 2002 Jul; 20(1):14-21. PubMed ID: 12100412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.